Dominik Mumberg

7PUBLICATIONS
50CO-AUTHORS
Haematological tumoursMolecular targetsRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Medical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 17, 2026
ADCE-T02 - a Next Generation Antibody Drug Conjugate Targeting Tissue Factor Demonstrates Superior Preclinical Efficacy and Tolerability.

|Jul 16, 2025
The Recycling Collagen Receptor uPARAP Is a Unique Mediator of Stromal Drug Delivery to Carcinoma Cells.

Kirstine S Nørregaard, Ida M E Larsen, Henrik J Jürgensen

|Aug 26, 2023
Zoledronic Acid Prevents Bone Resorption Caused by the Combination of Radium-223, Abiraterone Acetate, and Prednisone in an Intratibial Prostate Cancer Mouse Model.

Mari I Suominen, Matias Knuuttila, Birgitta Sjöholm

|Jun 26, 2023
A Targeted Thorium-227 Conjugate Demonstrates Efficacy in Preclinical Models of Acquired Drug Resistance and Combination Potential with Chemotherapeutics and Antiangiogenic Therapies.

Sabine Zitzmann-Kolbe, Alexander Kristian, Dieter Zopf

|Feb 11, 2023
Enhanced Antitumor Efficacy of Radium-223 and Enzalutamide in the Intratibial LNCaP Prostate Cancer Model.

Mari I Suominen, Matias Knuuttila, Christoph A Schatz

|Jun 02, 2021
Additive Benefits of Radium-223 Dichloride and Bortezomib Combination in a Systemic Multiple Myeloma Mouse Model.

Mari I Suominen, Jenni Mäki-Jouppila, Anna Huhtinen

Pageof 2

Frequent Collaborators

3 joint publications

Mari I Suominen

2 joint publications

Christoph A Schatz

2 joint publications

Sanna-Maria Käkönen

2 joint publications

Thomas T Poulsen